LeonaBio, Inc. (LONA)
4.70
-0.07
(-1.47%)
USD |
NASDAQ |
Nov 04, 14:13
LeonaBio Price : 4.70 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 4.69 | 4.90 | 4.69 | 4.77 | 28493.00 |
| Nov 02, 2026 | 4.95 | 5.03 | 4.63 | 4.73 | 26742.00 |
| Oct 30, 2026 | 4.89 | 5.14 | 4.76 | 4.94 | 43068.00 |
| Oct 29, 2026 | 5.20 | 5.400 | 4.74 | 4.91 | 162054.0 |
| Oct 28, 2026 | 4.94 | 5.10 | 4.76 | 4.96 | 124787.0 |
| Oct 27, 2026 | 4.77 | 5.10 | 4.68 | 4.89 | 118702.0 |
| Oct 26, 2026 | 4.80 | 5.00 | 4.55 | 4.76 | 38900.00 |
| Oct 23, 2026 | 4.99 | 5.02 | 4.83 | 4.84 | 33791.00 |
| Oct 22, 2026 | 5.59 | 5.671 | 4.69 | 4.97 | 49805.00 |
| Oct 21, 2026 | 5.30 | 5.75 | 5.30 | 5.67 | 11773.00 |
| Oct 20, 2026 | 5.11 | 5.46 | 4.86 | 5.27 | 61515.00 |
| Oct 19, 2026 | 5.23 | 5.385 | 4.77 | 5.05 | 41141.00 |
| Oct 16, 2026 | 5.30 | 5.43 | 5.15 | 5.20 | 61330.00 |
| Oct 15, 2026 | 5.41 | 5.44 | 4.910 | 5.29 | 35247.00 |
| Oct 14, 2026 | 6.33 | 6.33 | 5.25 | 5.39 | 103022.0 |
| Oct 13, 2026 | 6.06 | 6.72 | 5.649 | 6.43 | 57428.00 |
| Oct 12, 2026 | 5.82 | 6.397 | 5.57 | 6.165 | 386342.0 |
| Oct 09, 2026 | 5.82 | 6.10 | 5.56 | 5.75 | 66684.00 |
| Oct 08, 2026 | 5.78 | 6.070 | 5.515 | 5.75 | 134603.0 |
| Oct 07, 2026 | 5.77 | 6.21 | 5.61 | 5.83 | 178059.0 |
| Oct 06, 2026 | 5.63 | 5.88 | 5.25 | 5.75 | 175828.0 |
| Oct 05, 2026 | 4.75 | 5.72 | 4.51 | 5.58 | 296080.0 |
| Oct 02, 2026 | 4.44 | 4.90 | 4.18 | 4.82 | 332594.0 |
| Oct 01, 2026 | 3.515 | 5.340 | 3.42 | 4.38 | 6.300M |
| Sep 30, 2026 | 3.51 | 3.59 | 3.31 | 3.57 | 40258.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.02 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Arvinas, Inc. | 7.45 |
| Fulcrum Therapeutics, Inc. | 3.775 |
| Definium Therapeutics, Inc. | 32.69 |
Price Related Metrics
| PEG Ratio | -0.0008 |
| Price to Book Value | 1.318 |
| Earnings Yield | -491.7% |
| Market Cap | 44.28M |
| PEGY Ratio | -0.0008 |